Announcements Trials
Browse Landscape

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Observational 1

Sponsor

Cancer Type

Other hematologic neoplasm 1Classical hematology 1

Conditions

Leukemia, Myeloid, Acute 103Precursor Cell Lymphoblastic Leukemia-Lymphoma 93Myelodysplastic Syndromes 89Leukemia 79Lymphoma 71Lymphoma, Non-Hodgkin 70Leukemia, Lymphocytic, Chronic, B-Cell 65Hodgkin Disease 55Multiple Myeloma 49Lymphoma, Mantle-Cell 42Lymphoma, Follicular 41Burkitt Lymphoma 39Lymphoma, Large B-Cell, Diffuse 38Lymphoma, B-Cell, Marginal Zone 36Lymphoma, Large-Cell, Immunoblastic 33Myeloproliferative Disorders 32Hematologic Neoplasms 32Leukemia, Myelogenous, Chronic, BCR-ABL Positive 30Neoplasms, Plasma Cell 27Leukemia, Myeloid, Accelerated Phase 25Leukemia, Myeloid, Chronic-Phase 24Congenital Abnormalities 24Leukemia, Myelomonocytic, Chronic 23Graft vs Host Disease 22Dendritic Cell Sarcoma, Interdigitating 21Recurrence 20Anemia, Refractory, with Excess of Blasts 20Waldenstrom Macroglobulinemia 18Blast Crisis 18Primary Myelofibrosis 17

Interventions

fludarabine phosphate 2fludarabine 2AP 1903 reagent 2ruxolitinib 1Whole-Body Irradiation 1Thiotepa 1Peripheral Blood Stem Cell Transplantation 1Panobinostat 1Melphalan 1Cyclophosphamide 1Clofarabine 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Thalassemia × Melphalan × Other hematologic neoplasm × Clear all
NCT03609827 2021-10-04

Study of Melphalan Drug Exposure in Pediatric Hematopoietic Stem Cell Transplant Patients

University of California, San Francisco

Completed
25 enrolled
Classical hematologyOther hematologic neoplasm

Anemia, Sickle Cell, Fanconi Anemia, Hemoglobinopathies, Immunologic Deficiency Syndromes, Thalassemia, Hematologic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡